Latent diffusion designs antimicrobial peptides active against fungi and drug-resistant bacteria
A latent-diffusion and molecular-dynamics pipeline generated and filtered peptide sequences; 40 synthesized candidates were tested, and 25 met the study's MIC threshold for antibacterial or antifungal activity. AMP-29 showed activity against Candida glabrata and efficacy in a murine skin-infection model, while AMP-24 showed in-vitro Gram-negative activity and efficacy in murine Acinetobacter baumannii skin and lung infection models.
Technology: Latent diffusion model coupled to molecular dynamics and peptide filtering/ranking
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: A latent-diffusion and molecular-dynamics pipeline generated and filtered peptide sequences; 40 synthesized candidates were tested, and 25 met the study's MIC threshold for antibacterial or antifungal activity.
- Still unknown: Twenty-five of 40 tested peptides met the authors' stated MIC ≤200 μM activity threshold, which includes a broad range of potency. The murine efficacy reports concern selected peptides and infection models, not human treatment. Some fungal peptides showed hemolysis; favorable safety cannot be generalized to the whole set.
- AI role: The diffusion model generated a diverse peptide sequence set, and computational filtering selected 40 candidates for chemical synthesis and experimental antimicrobial testing; the selected peptides included leads taken into mouse infection models.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11797553/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 103 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.